Organigram Holdings Inc.

Equities

OGI

CA68620P7056

Healthcare Facilities & Services

Market Closed - Toronto S.E. Other stock markets 16:00:00 2024-07-17 EDT			5-day change	1st Jan Change
2.32 ^CAD	-2.11%		+6.42%	+34.88%

06-25	Organigram to Invest $15 Million in German Cannabis Company Sanity Group	MT
06-25	Organigram to Buy Minority Stake in German Cannabis Firm Sanity Group for 14 Million Euros	MT

Organigram Holdings Inc. Reports Earnings Results for the First Quarter Ended November 30, 2020

January 12, 2021 at 07:06 am

OrganiGram Holdings Inc. announced earnings results for the first quarter ended November 30, 2020. For the first quarter, the company announced total revenue was CAD 19.331 million compared to CAD 25.153 million a year ago. Operating loss was CAD 28.213 million compared to operating Income of CAD 154,000 a year ago. Net loss was CAD 34.336 million compared to CAD 863,000 a year ago. Basic loss per share from continuing operations was CAD 0.17 compared to CAD 0.006 a year ago.

Latest news about Organigram Holdings Inc.

Organigram to Invest $15 Million in German Cannabis Company Sanity Group	06-25	MT
Organigram to Buy Minority Stake in German Cannabis Firm Sanity Group for 14 Million Euros	06-25	MT
Organigram Brief: Investing in Sanity Group, a Leading German Cannabis Company	06-25	MT
The Sanity Group GmbH announced that it has received ?14 million in funding from Organigram Holdings Inc.	06-24	CI
Organigram Signs Three-Year Supply Agreement With Avida Medical in UK	05-28	MT
Organigram to Supply U.K.'s Avida Medical With Dried Cannabis Flower in Three-Year Deal	05-28	MT
Organigram Brief: Says Signed Three Year Supply Agreement with Avida Medical in UK	05-28	MT
Organigram Signs Three Year Supply Agreement with Avida Medical in UK	05-28	CI
Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat	05-14	DJ
Transcript : Organigram Holdings Inc., Q2 2024 Earnings Call, May 14, 2024	05-14
Organigram Fiscal Q2 Loss Surges as Revenue Falls 5%	05-14	MT
Organigram Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-14	CI
Organigram Brief: Q2 Fiscal 2024 Net loss was $27.1 million compared to $7.5 million in Q2 Fiscal 2023	05-14	MT
Organigram Brief: Q2 Fiscal 2024 overall net revenue decreased 5% to $37.6 million, from $39.5 million in Q2 Fiscal 2023	05-14	MT
Organigram Brief: Q2 Fiscal 2024 recreational net revenue increased 21% to $33.1 million from $27.4 million in the second quarter ended February 28, 2023	05-14	MT
North American Morning Briefing : Powell Comments, -2-	04-16	DJ
Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	04-15	MT
Organigram Holdings Completes Underwritten Public Offering	04-02	MT
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot	04-02	MT
Organigram Reports Overnight Marketed Public Offering; Down Over 19%	03-27	MT
Organigram Reports Overnight Marketed Public Offering	03-27	MT
Organigram Reports Minority Investment in Open Book Extracts; Up 8.8%	03-26	MT
Organigram Up 2.2% In US Premarket After Receiving Health Canada's Final Redetermination on Jolts	03-25	MT
Organigram Holdings Inc. Receives Health Canada?S Final Redetermination on Jolts	03-22	CI
Organigram Notes The Standing Committee on Finance's Recommendation on Excise Duty	02-28	MT

Chart Organigram Holdings Inc.

Duration

Period

More charts

Company Profile

Organigram Holdings Inc. operates through its subsidiaries. The Companyâs major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing cannabis for patients and adult recreational consumers, as well as developing international business partnerships. It has also developed and owns a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag Oâ Buds, SHRED, SHREDâems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. 10870277 Canada Inc. is a special purpose holding company for the Company. EIC is a cannabis processor of confectionary goods.

Sector

Healthcare Facilities & Services

Calendar

2024-11-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Organigram Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.32 CAD

Average target price

3.621 CAD

Spread / Average Target

+56.10%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
ORGANIGRAM HOLDINGS INC.	+34.88%	176M
AYR WELLNESS INC.	+23.05%	247M
ASCEND WELLNESS HOLDINGS, INC.	-11.34%	183M
IANTHUS CAPITAL HOLDINGS, INC.	-42.86%	96.83M
JUSHI HOLDINGS INC.	+26.09%	114M
BAKHU HOLDINGS, CORP.	+270.00%	111M
INTERCURE LTD.	+92.85%	111M
THE CANNABIST COMPANY HOLDINGS INC.	-52.78%	99.75M
4FRONT VENTURES CORP.	+15.38%	100M

Medical Farming